March | 2008 | GlobeImmune

GlobeImmune Announces Appointment of J. William Freytag Ph.D to GlobeImmune Board of Directors

March 25, 2008

LOUISVILLE, CO, March 25, 2008 – GlobeImmune, Inc. announced today the addition of J. William Freytag, Ph.D. to its Board of Directors. “Dr. Freytag brings over 25 years of research, product development and commercialization experience to the Board,” said Timothy … Continue reading →

GlobeImmune Announces Initiation of a Phase 2a Clinical Trial of GI-4000 in Patients with Non-Small Cell Lung Cancer at Memorial Sloan Kettering

March 19, 2008

FOR IMMEDIATE RELEASE GlobeImmune Announces Initiation of a Phase 2a Clinical Trial of GI-4000 in Patients with Non-Small Cell Lung Cancer at Memorial Sloan Kettering LOUISVILLE, CO, March 19, 2008 – GlobeImmune, Inc. announced today the initiation of a Phase … Continue reading →